The presence of ALT in CML during the CP strongly suggests that ALT might be required at the early stages of leukemogenesis, potentially by conferring a necessary proliferative advantage. This evidence concerns the gene GPT and chronic myelogenous leukemia, BCR-ABL1 positive.